Earnings Call · Q1 FY2025·2025-05-07

Q1 25EPS +3.45%·Rev n/aQ4 24EPS -2.18%·Rev n/aQ3 24EPS +60.00%·Rev n/aQ2 24EPS -5.26%·Rev n/a⚠ consensus missing

Skye Bioscience, Inc. SKYE

Bernie Hertel

Punit Dhillon — Chief Executive Officer

Christopher Twitty — Chief Scientific Officer

Kaitlyn Arsenault — Chief Financial Officer

+1.1%1d on move date+1.2% vs SPY3d+8.4%5d+12.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SKYE calls or request research access.

More SKYE calls Browse calls Request research access